CAPDM - 2019 Annual Conference Speakers
Meet our 2019 Conference Speakers
"Blockchain for Life Sciences: A Year Later, What Has Changed?"
Mark Treshock, Global Blockchain Solutions Leader, Healthcare and Life Sciences, IBM Global Business Services
Blockchain is gaining a lot of attention as a technology poised to disrupt with its far-reaching implications. Blockchain can do for business what the internet did for communication. Leading IBM’s strategy for blockchain solutions, Mark is a skillful presenter who delivers clarity and understanding to a technology that has proven to be difficult to understand.
“Trends in Artificial Intelligence”
Hod Lipson, PhD, Professor Engineering & Data Sciences, Columbia University
Hod Lipson’s work on self-aware and self-replicating robots has challenged conventional views of robotics, garnering widespread media attention. He has co-authored over 300 publications that received over 14,000 citations to date. Hod directs the Creative Machines Lab, which pioneers new ways to make machines that create, and machines that are creative.
"Likelihood of National Pharmacare in Canada"
Thomas S. Axworthy, Distinguished Fellow, Munk School of Global Affairs & Public Policy. Chair of Public Policy at Massey College, University of Toronto.
With a distinguished career in government, academia and a lifetime of public policy work, Dr. Axworthy is well equipped to deliver political insights into this very important national file, particularly in the context of an election year. He will examine the federal, provincial dynamics of implementing pharmacare and evaluate the file from a pre and post-election scenario.
“The Future for Cannabis in Canada”
Philippe Lucas, Vice President, Patient Research and Access, Tilray
Philippe will examine the commercial and regulatory future for Cannabis in Canada. Complementing his role at Tilray, Philippe is a PhD student in the University of Victoria’s Social Dimensions of Health program and a Graduate Researcher with the Center for Addictions Research of British Columbia. He frequently provides expert testimony to various levels of government.
“Evolution of Prior Authorization & Specialty Drug Management in Self-Insured Drug Plans”
Mike Sullivan, President, Cubic Health Inc.
Mike Sullivan is CEO and Co-Founder of Cubic Health, the leading analytics and clinical solutions company servicing the employee benefits industry in Canada. Cubic works with employer plans and trusts that range in size from 500 to 600,000 employee lives with the goal of optimizing the health of both plan members and the plan itself.
“How New Legislation Impacts the Workplace”
Gary Goodwin, Counsel, Ducks Unlimited Canada
Gary Goodwin is in-house counsel for the conservation organization, Ducks Unlimited Canada. His work covers a broad range of contractual, employment, and real estate issues. In addition to his law degree and MBA, he completed his LLM from London England emphasizing natural resources and international economic regulation.
“Pharmaceutical Market Update – Dynamics, Trends & Points of Interest”
Ryan Norman, GM, Supplier Relations & HIIS, IQVIA
Ryan was appointed GM, Supplier Relations at the end of 2018, now working with internal & external stakeholders to maintain and expand IQVIA’s visibility to the pharmaceutical marketplace. Ryan draws upon many years of experience from various roles in sales and consulting in the healthcare space. Leading the IQVIA Health Industry Information Services (HIIS) business development efforts for pharmacy and wholesale clients, Ryan delivers insights that provide a better understanding of our complex marketplace, enabling them to make more effective business decisions.
“The Amazon Omnichannel Imperative”
D. Bruce Merrifield, Jr., President, Merrifield Consulting
Perhaps no one has studied the impact of disruptive technologies, including Amazon’s escalating threats to legacy B2B channels, more than Bruce Merrifield. He is an expert turn-around advisor for wholesale distribution, and has been writing and lecturing on tactics and best practices for more than three decades.